Glenmark Pharmaceuticals Ltd.

NSE: GLENMARK | BSE: 532296

Strong Performer, Getting Expensive

Download real time

2219.20 38.10 (1.75%)

New 52W High in past week

3.8M NSE+BSE Volume

High vol.+gain this week

NSE 14 Jul, 2025 3:31 PM (IST)

62,626

Market Cap

High in industry

0.7

Beta 1Year

Very Low volatility

Analyst Buy

Motilal Oswal retains 'Buy' call on Glenmark Pharma, expects a revenue CAGR of 10.6% over FY26-27 See details

Glenmark Pharmaceuticals Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for GLENMARK, BSE:532296 Glenmark Pharmaceuticals Ltd.

Is Glenmark Pharmaceuticals Ltd. worth buying?

568 Votes:

Buy 79.23%

Sell 13.73%

Hold 7.04%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >